Latest News

Mar 31, 2020

Propanc Biopharma Enters Into a $3 Million Financing with Institutional Investor

Company Plans to Undertake GMP Manufacture of PRP for a First-In-Human (FIH) Study in Advanced Cancer Patients MELBOURNE, Australia--(BUSINESS WIRE)-- Propanc Biopharma, Inc. (OTC: PPCB) (“Propanc” or the…

View All Press Releases